Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2008
10/15/2008CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
10/15/2008CN101284810A Cyano-pyrrolidine and cyano-tetrahydrothiazole derivates
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425592C Indole derivatives
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435828 immunosuppressive agents; low dosages; 5-[4-(2-hydroxy-ethoxy)-benz[Z]ylidene]-2-([Z]-isopropylimino)-3-o-tolyl-thiazolidin-4-one
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435815 Sulfonylamino-acetic acid derivatives
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435748 Alzheimer's disease; bridged bicycloalkyl spirocyclic sulphonamide derivatives; oral administration
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008CA2497345C Novel quaternary ammonium compounds
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008121877A2 Cftr inhibitor compounds and uses thereof
10/09/2008WO2008121861A2 Pyrazole and pyrrole compounds useful in treating iron disorders
10/09/2008WO2008121670A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008WO2008121592A2 Acetyl coenzyme a carboxylase inhibitors
10/09/2008WO2008121558A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/09/2008WO2008121415A2 Improved process for preparing quetiapine fumarate
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120754A1 Picolinamide compound
10/09/2008WO2008120744A1 Five-membered cyclic amide compound and use thereof
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008119563A2 Method for producing epothilone derivatives by means of selective catalytic epoxidation
10/09/2008WO2008101682A3 Iminipyridine derivatives and their uses as microbiocides
10/09/2008WO2008022002A3 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008US20080249148 For contraception, treating or preventing fibroids, uterine leiomyomata, endometriosis, dysfunctional bleeding, polycystic ovary syndrome, and hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake, and synchronizing estrus
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080249095 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008CA2682629A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2681806A1 Process for preparing epothilone derivatives by selective catalytic epoxidation
10/09/2008CA2681586A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/08/2008EP1978023A1 Pyridazines as fungicides
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976851A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
10/08/2008EP1660493B1 Peptidyl heterocyclic ketone derivatives and preparation processes
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1569931B1 Heterocyclic compounds as ccr5 antagonists
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008CN101282979A Composition containing chloromethyl phosphate derivative with improved stability and process for producing the same
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282971A Chemical process for the preparation of benzoxazole derivatives used as pesticides
10/08/2008CN101282970A Chemical process
10/08/2008CN101282969A Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282951A N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282950A Novel benzothiazolone derivatives
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282942A Imidazole derivatives for the treatment of anxiety and related diseases
10/08/2008CN101279971A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432292 Anticancer agents; autoimmune diseases; antiinflammatory agents; ; graft versus host disease; Crohn's diseases; skin disorders
10/07/2008US7432291 Anticancer, antitumor agents; compounds are 1-(2-(phenethenyl)oxazol-4-ylmethoxy)-4-(1,2,3-triazolylethoxymethyl)-benzenes or corresponding derivatives where oxazole is replaced by thiazole
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432269 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008US7432260 Pyrimidine compounds
10/07/2008US7432257 Piperdinyl-phenoxazine and phenothiazine derivatives as δ-opioid modulators
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2433772C Pyrimidine matrix metalloproteinase inhibitors
10/07/2008CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2248143C Process to prepare oxazolidinones
10/02/2008WO2008118718A2 2-aminopyridine analogs as glucokinase activators
10/02/2008WO2008117982A1 Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117050A1 Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer
10/02/2008WO2008116881A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
10/02/2008WO2008116831A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/02/2008WO2008098949A3 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2008092954A3 Polymorphic forms of a macrocyclic inhibitor of hcv
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 628